The normal function of the cancer kinase Mirk/dyrk1B is to reduce reactive oxygen species

Genes and Cancer

Volumn 5, Issue 1-2, 2015, Pages 22-30

  Deng, Xiaobing ^a   Mercer, Stephen E ^a   Sun, Chi Yu ^a   Friedman, Eileen ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Antioxidant genes; Fast twitch muscle; Mirk dyrk1B; ROS

Indexed keywords

DUAL SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 1B; ENZYME; GLUTATHIONE PEROXIDASE; HISTONE DEACETYLASE; MIRK KINASE; MYOGENIN; PEROXIREDOXIN 2; REACTIVE OXYGEN METABOLITE; SHORT HAIRPIN RNA; TROPONIN T; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MIRK KINASE GENE; MOUSE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING.;

EID: 84945931390     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Friedman E. Mirk/dyrk1B in cancer. J Cell. Biochem. 2007;102(2):274-9.
2. Leder S, Czajkowska H, Maenz B, de Graaf K, Barthel A, Joost H-G, et al. Alternative splicing variants of the protein kinase DYRK1B exhibit distinct patterns of expression and functional properties. Biochem J. 2003;372:881-8.
3. Deng X, Mercer SE, Shah S, Ewton DZ, Friedman E. The Cyclin-dependent Kinase Inhibitor p27Kip1 Is Stabilized in G0 by Mirk/dyrk1B Kinase. J Biol Chem 2004;279(21):22498-504.
4. Zou Y, Ewton D, Deng D, Mercer S, Friedman E. Mirk/dyrk1B Kinase Destabilizes Cyclin D1 by Phosphorylation at Threonine 288. J Biol Chem. 2004;279:27790-8.
5. Dhawan J, Helfman DM. Modulation of acto-myosin contractility in skeletal muscle myoblasts uncouples growth arrest from differentiation. J Cell Sci. 2004;117(Pt 17):3735-48.
6. Sambasivan R, Cheedipudi S, Pasupuleti N, Saleh A, Pavlath GK, Dhawan J. The small chromatin-binding protein p8 coordinates the association of anti-proliferative and pro-myogenic proteins at the myogenin promoter. J Cell Sci. 2009;122(Pt 19):3481-91. PMCID: 2746131.
7. Zhang J-M, Zhao X, Wei Q, Paterson BM. Direct inhibition of G1 cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation. EMBO J. 1999;18(24):6983-93.
8. Deng X, Ewton DZ, Pawlikowski B, Maimone M, Friedman E. Mirk/dyrk1B Is a Rho-induced Kinase Active in Skeletal Muscle Differentiation. J Biol Chem 2003;278(42):41347-54.
9. Mercer S, Friedman E. Mirk/Dyrk1B: a multifunctional dual-specificity kinase involved in growth arrest, differentiation and cell survival. Cell Biochem. Biophys. 2006;45:303-15.
10. Deng X, Ewton DZ, Mercer SE, Friedman E. Mirk/dyrk1B Decreases the Nuclear Accumulation of Class II Histone Deacetylases during Skeletal Muscle Differentiation. J Biol Chem 2005;280(6):4894-905.
11. Mercer SE, Ewton DZ, Deng X, Lim S, Mazur TR, Friedman E. Mirk/Dyrk1B Mediates Survival during the Differentiation of C2C12 Myoblasts. J Biol Chem. 2005;280(27):25788-801.
12. Lee K, Deng X, Friedman E. Mirk Protein Kinase Is a Mitogen-activated Protein Kinase Substrate That Mediates Survival of Colon Cancer Cells. Cancer Res. 2000;60(13):3631-7.
13. Mercer SE, Ewton DZ, Shah S, Naqvi A, Friedman E. Mirk/ Dyrk1b Mediates Cell Survival in Rhabdomyosarcomas. Cancer Res 2006;66(10):5143-50.
14. Ji LL, Gomez-Cabrera M-C, Vina J. Role of Free Radicals and Antioxidant Signaling in Skeletal Muscle Health and Pathology Infect Disord Drug Targets. 2009;9(4):428-44.
15. Zou Y, Lim S, Lee K, Deng X, Friedman E. Mirk/Dyrk1B is an inhibitor of epithelial cell migration which negatively regulated by the Met-adaptor ranBPM. J Biol Chem. 2003; 278: 49573-81.
16. Litovchick L, Florens LA, Swanson SK, Washburn MP, DeCaprio JA. DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly. Genes & Dev. 2011;25(8):801-13.
17. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate. Cancer Cell. 2006;10:241-52.
18. Deng X, Ewton DZ, Friedman E. Mirk/Dyrk1B maintains the viability of quiescent pancreatic cancer cells by decreasing ROS levels. Cancer Res. 2009;69(8):3317-24.
19. Thompson FH, Nelson MA, Trent JM, Guan X-Y, Liu Y, Yang J-M, et al. Amplification of 19q13.1-q13.2 sequences in ovarian cancer : G-band, FISH, and molecular studies. Cancer Gen. Cytogen. 1996;87(1):55.
20. Kuuselo R, Savinainen K, Azorsa DO, Basu GD, Karhu R, Tuzmen S, et al. Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification. Cancer Res 2007;67(5):1943-9.
21. Murphy MP. Modulating mitochondrial intracellular location as a redox signal. Sci Signal. 2012;5(242):pe39.
22. Malinska D, Kudin AP, Bejtka M, Kunz WS. Changes in mitochondrial reactive oxygen species synthesis during differentiation of skeletal muscle cells. Mitochondrion. 2012;12(1):144-8.
23. Gilliam LA, Moylan JS, Patterson EW, Smith JD, Wilson AS, Rabbani Z, et al. Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes. Am J Physiol Cell Physiol. 2012;302(1):C195-202. PMCID: 3328915.
24. Michaelson LP, Shi G, Ward CW, Rodney GG. Mitochondrial redox potential during contraction in single intact muscle fibers. Muscle Nerve. 2010;42(4):522-9. PMCID: 3015179.
25. Hu J, Friedman E. Depleting Mirk Kinase Increases Cisplatin Toxicity in Ovarian Cancer Cells. Genes & Cancer. 2010;1:803-11.
26. Won H, Lim S, Jang M, Kim Y, Rashid MA, Jyothi KR, et al. Peroxiredoxin-2 upregulated by NF-kappaB attenuates oxidative stress during the differentiation of muscle-derived C2C12 cells. Antioxid Redox Signal. 2012;16(3):245-61.